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Current guidelines recommend that the clinician, radiologist, and
pathologist work together to establish a diagnosis of idiopathic
interstitial pneumonia. Three clinicians, two radiologists, and two
pathologists reviewed 58 consecutive cases of suspected idiopathic
interstitial pneumonia. Each participant was provided information
in a sequential manner and was asked to record their diagnostic
impression and level of confidence at each step. Interobserver
agreement improved from the beginning to the end of the review.
After the presentation of histopathologic information, radiologists
changed their diagnostic impression more often than did clinicians.
In general, as more information was provided the confidence level
for a given diagnosis improved, and the diagnoses rendered with
a high level of confidence were more likely congruent with the final
pathologic consensus diagnosis. The final consensus pathologist
diagnosis was idiopathic pulmonary fibrosis in 30 cases. Clinicians
identified 75% and radiologists identified 48% of these cases before
presentation of the histopathologic information. Histopathologic
information has the greatest impact on the final diagnosis, espe-
cially when the initial clinical/radiographic diagnosis is not idio-
pathic pulmonary fibrosis. We conclude that dynamic interactions
between clinicians, radiologists, and pathologists improve interob-
server agreement and diagnostic confidence.
Keywords: diagnosis; nonspecific interstitial pneumonia; usual intersti-
tial pneumonia
Histopathologic subsets of idiopathic interstitial pneumonia ex-
hibit different prognoses (1–8). Therefore, an accurate diagnosis
is critical to the management of patients with idiopathic intersti-
tial pneumonia. Clinical features, high-resolution computed to-
mography (HRCT) (9–12), and surgical lung biopsy (13) all play
a role in establishing a diagnosis. An American Thoracic Society/
European Respiratory Society (ATS/ERS) committee empha-
sized the need for a dynamic diagnostic integrated process in
which clinicians, radiologists, and pathologists exchange infor-
mation in the determination of a diagnosis in individual patients
with suspected idiopathic interstitial pneumonia (14). Using his-
tology alone as the “gold standard” for diagnosis can be compli-
cated by difficulties with interrater agreement (15) and the potential
for sampling error (2). The combination of HRCT and histologic
features also better predicts prognosis compared with either
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modality alone (16). In the current study, we hypothesized that
an interactive process would improve the interobserver agree-
ment between expert clinicians, radiologists, and pathologists in
consecutive patients with suspected idiopathic interstitial pneu-
monia compared with each group working in diagnostic isolation.
This study illustrates that a consensus diagnosis, reached after
a careful exchange of clinical, radiographic, and histopathologic
information, often differs from the initial diagnosis reached by
the individual clinician, radiologist, or pathologist working in iso-
lation. Some of these results have been previously reported in
the form of an abstract (17, 18).
METHODS
Patient Selection
Patients in this study represented consecutive patients referred to the
University of Michigan Specialized Center of Research (SCOR) in the
Pathobiology of Fibrotic Lung Disease for potential participation in
research protocols between January 2002 and August 2002. Patients
with suspected idiopathic interstitial pneumonia were referred to the
study center by participants in the University of Michigan Fibrotic
Lung Disease Network (see acknowledgment). Through the course
of evaluation all patients underwent a history, physical examination,
complete pulmonary function testing, HRCT, and surgical lung biopsy.
Patients without an HRCT scan or a surgical lung biopsy were excluded.
Patients with known collagen vascular disease at the time of presenta-
tion were excluded. Patients without collagen vascular disease at initial
presentation, but that developed a discrete collagen vascular disease
during the course of follow-up, were included.
Data Collection
A standard form was used to collect clinical information including symp-
toms, environmental exposures, comorbid illnesses, medication use, smok-
ing history, family history, physical examination findings, and serologic
data. Pulmonary function data (spirometry, lung volumes, and diffusion
capacity for carbon monoxide) and HRCT within 6 months of surgical
lung biopsy were reviewed.
Pathology Interpretation
Two expert pulmonary pathologists (T.C. and W.T.) individually re-
viewed each patient’s surgical lung biopsy without clinical or HRCT
information. The slides from each patient’s surgical lung biopsy were
independently reviewed by the two pathologists before the study meet-
ing. At the study meeting, during Steps 1–3 (see below) the pathologists
were physically separated from the clinicians and radiologists and re-
solved individual differences in histopathologic opinion through joint
review and a consensus histopathologic diagnosis was reached.
Study Organizational Scheme
The overall study format was designed to evaluate whether the addition
of specific clinical, radiographic, and pathologic information impacted
the diagnostic impression of each participant. Participants met at the
University of Michigan and were given information in a stepwise fashion
as outlined below and in Figure 1. Participants could change diagnostic
impression and/or level of confidence at each step of the review process.
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Figure 1. Schematic representation of the information presented to each
of the participants at each step of the study. HRCT  high-resolution
computed tomography; IPF idiopathic pulmonary fibrosis; SLB surgi-
cal lung biopsy. Individuals made their diagnostic decisions without con-
ferring in Steps 1 and 2 and individually after conferring in Steps 3–5.
TABLE 1. DIAGNOSIS OF EACH PARTICIPANT THROUGH EACH STEP OF THE STUDY
Clinician Radiologist Consensus
A B C A B Pathologist
Step 1
IPF 28 17 24 15 15 NA
NSIP 20 32 19 27 27 NA
RBILD/DIP 7 1 2 1 2 NA
Hypersensitivity pneumonitis 3 4 6 11 13 NA
Bronchiolar disease 0 1 0 0 0 NA
Other 0 3 7 4 1 NA
Step 2
IPF 28 19 24 15 15 NA
NSIP 21 26 19 25 25 NA
RBILD/DIP 4 3 5 2 3 NA
Hypersensitivity pneumonitis 4 4 5 13 12 NA
Bronchiolar disease 1 1 1 0 0 NA
Other 0 5 4 3 3 NA
Step 3
IPF 24 23 24 15 16 NA
NSIP 24 21 21 24 24 NA
RBILD/DIP 4 4 3 3 3 NA
Hypersensitivity pneumonitis 5 4 5 13 12 NA
Bronchiolar disease 1 1 1 1 0 NA
Other 0 5 4 2 3 NA
Step 4
IPF 32 29 29 32 30 30
NSIP 15 16 12 12 15 15
RBILD/DIP 3 5 3 1 2 1
Hypersensitivity pneumonitis 3 3 4 3 3 1
Bronchiolar disease 1 1 3 4 4 6
Other 4 4 7 6 4 5
Step 5
IPF 31 29 30 30 30 30
NSIP 15 19 14 14 15 15
RBILD/DIP 4 4 2 1 2 3
Hypersensitivity pneumonitis 3 3 4 3 3 1
Bronchiolar disease 1 0 3 5 4 4
Other 4 3 5 5 4 5
Definition of abbreviations: IPF  idiopathic pulmonary fibrosis; NA  not applicable; NSIP  nonspecific interstitial pneumonia;
RBILD/DIP  respiratory bronchiolitis interstitial lung disease/desquamative interstitial pneumonia.
Step 1: Expert clinicians (J.L., T.K., and G.R.) and radiologists (E.K.
and B.G.) independently reviewed HRCTs without clinical
or pathologic information. Each participant was asked inde-
pendently to provide their opinion as to the most likely
diagnosis and a confidence level for that diagnosis (1 definite,
2 probable, 3 possible, 4 definitely not). Acknowledging
the prognostic importance of usual interstitial pneumonia
(UIP), participants were asked to record their confidence that
the case could represent UIP.
Step 2: Clinicians and radiologists reviewed HRCTs with a standard-
ized presentation of clinical information and recorded their
diagnostic impression and confidence as in Step 1; no discus-
sion occurred between the participants.
Step 3: Clinicians and radiologists discussed diagnostic impressions
and again recorded their individual diagnosis and confidence
level.
Step 4: Pathologists (T.C. and W.T.) entered the study arena. The
standardized clinical information and HRCT were again re-
viewed. The pathologists then discussed their interpretation
of the surgical lung biopsy. The clinicians, radiologists, and
pathologists discussed each case and again recorded their
individual final clinical, radiologic, and pathologic diagnosis
and confidence level. For this part of the study the two
pathologists functioned as a single observer, that is, they did
not each record their individual interpretation.
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TABLE 2. DIAGNOSIS BY PATHOLOGIST WITHOUT
CLINICAL OR RADIOGRAPHIC INFORMATION
Diagnosis Pathologist A Pathologist B Consensus
IPF 27 28 30
NSIP 11 14 15
RBILD/DIP 1 1 3
Hypersensitivity pneumonitis 2 1 1
Bronchiolar disease 7 4 4
Other 10 10 5*
Definition of abbreviations: IPF  idiopathic interstitial pneumonia, NSIP  non-
specific interstitial pneumonia, RBILD/DIP  respiratory bronchiolitis interstitial
lung disease/desquamative interstitial pneumonia.
* Other diagnoses were as follows: diffuse alveolar damage (n  2), cellular
interstitial pneumonia with granulomas and possible atypical mycobacterial dis-
ease, poor biopsy specimen, and pulmonary veno-occlusive disease.
Step 5: Participants discussed their own interpretation of each case.
When disagreement was present an attempt was made to
reach a consensus diagnosis. A consensus clinical, radiologic,
and pathologic diagnosis could not be reached in all cases
and therefore all participants again recorded their individual
diagnoses and confidence levels.
Statistical Analysis
Each observer’s diagnosis was coded into one of six categories—
idiopathic pulmonary fibrosis (IPF), nonspecific interstitial pneumonia
(NSIP), respiratory bronchiolitis interstitial lung disease/desquamative
interstitial pneumonia (RBILD/DIP), hypersensitivity pneumonitis,
bronchiolar disease, and other. McNemar tests were subsequently used
to test whether two probabilities of agreement conducted during differ-
ent steps or by different raters were equal. A  statistic allowing for
multiple raters was also used to assess agreement in diagnosis.  Scores
are rated as almost perfect agreement (above 0.8), substantial agree-
ment (scores between 0.6 and 0.8), moderate agreement (scores between
0.4 and 0.6), fair agreement (scores between 0.2 and 0.4), slight agree-
ment (scores between 0.0 and 0.2), and poor agreement (scores below
0.0) (19). An estimating equation approach to the analysis of correlated
 statistics was used in comparisons of  statistics estimated throughout
the study and in producing confidence intervals for the  statistics (20).
A 2 or Fisher exact test was used to examine the relationship between
the confidence of each participant for their diagnosis and the final
pathologist consensus diagnosis. A recorded confidence level of 1 was
considered high in confidence and a confidence level of 2, 3, or 4 was
considered low in confidence.
RESULTS
Fifty-eight patients were evaluated. The  for the two patholo-
gists without clinical or radiologic information (pathology review
before Step 1) was 0.72 (95% confidence interval, 0.57 to 0.86)
with a probability of agreement of 0.81 (95% confidence interval,
0.71 to 0.91). IPF and NSIP were the most common diagnoses
(Tables 1 and 2). In general, agreement among clinicians and
between clinicians and radiologists improved when more data
(clinical, radiographic, and pathologic) were provided (Table 3).
TABLE 3. INTEROBSERVER AGREEMENT AT EACH DIAGNOSTIC STEP
Clinicians Radiologists Clinicians–Radiologists All Observers
Step [ (95% CI)] [ (95% CI)] [ (95% CI)] [ (95% CI)]
1 0.41 (0.29, 0.52) 0.72 (0.57, 0.86) 0.39 (0.29, 0.49) NA
2 0.51 (0.37, 0.64) 0.80 (0.67, 0.93) 0.44 (0.34, 0.54) NA
3 0.67 (0.54, 0.79) 0.78 (0.65, 0.91) 0.55 (0.44, 0.66) NA
4 0.75 (0.64, 0.86) 0.84 (0.72, 0.96) 0.78 (0.70, 0.86) 0.79 (0.71, 0.86)
5 0.86 (0.76, 0.95) 0.90 (0.80, 0.99) 0.88 (0.81, 0.96) 0.88 (0.81, 0.94)
Definition of abbreviations: CI  confidence interval for corresponding statistic; NA  not applicable.
Importantly, when pathology results were provided to the group,
the radiologists were more likely to alter their interpretation
than were the clinicians, as enumerated by the decrease in in-
traobserver  coefficient between Steps 3 and 4 (Table 4).
The agreement level of clinicians and radiologists with the
pathologist consensus diagnosis tended to increase as additional
information was provided (Table 5). Importantly, a diagnosis of
IPF by each clinician or each radiologist following the review of
clinical and radiographic data (before pathologic data) coincided
with the pathologic diagnosis in all but two cases. For one case
two clinicians and both radiologists changed their diagnosis to
NSIP; in a separate case one clinician changed to a diagnosis
of desquamative interstitial pneumonia. Furthermore, clinicians
correctly diagnosed more cases of IPF that were subsequently
pathologically confirmed as IPF compared with radiologists at
this step (Step 3) of the study. After pathologic impressions were
provided to the group, the radiologists changed their interpreta-
tions to a greater extent. This is suggested by the marked im-
provement in interobserver agreement between radiologists and
pathologists (Table 5) and the lower radiologist intraobserver
agreement level (Table 4). The radiologists most often changed
their diagnosis of NSIP to IPF and changed diagnoses of hyper-
sensitivity pneumonitis and RBILD/DIP to NSIP (data not
shown). The pathologists changed their initial consensus impres-
sions (n  11) less often than the clinicians (n  27, 17, 15) or
radiologists (n 34, 28). These data reflect the change in diagno-
sis for the pathologists between their initial consensus review
before obtaining clinical and radiographic information; for clini-
cians and radiologists the change reflects a change from each
individual’s diagnosis after a clinical and radiologic discussion
(Step 3) but before histopathologic discussion (Step 5). When
the pathologists changed their initial consensus impressions,
their final diagnoses are listed in Table 6. It is notable that in
three cases a histologic diagnosis of UIP was thought not to
represent IPF after review of clinical and HRCT data. We were
not able to identify unique clinical or radiographic features that
could reliably predict non-IPF idiopathic interstitial pneumonia
diagnoses without a surgical lung biopsy.
Clinicians tended to be more confident than radiologists in
the early steps of the evaluation process, although the number
of confident diagnoses increased for all observers as more infor-
mation was provided (Table 7). A statistically significant rela-
tionship between confidence in diagnosis and final diagnosis
was more often seen with clinicians compared with radiologists,
particularly in the early compared with late stages of the evalua-
tion process. An increase in confidence was noted with the addi-
tion of pathologic data for both clinicians and radiologists.
Total agreement (3 clinicians, 2 radiologists, and 2 patholo-
gists) on a final diagnosis was reached in 47 (81%) of the cases
(IPF, n  28; NSIP, n  13; RBILD, n  1; hypersensitivity
pneumonitis, n  1; other, n  4). In 6 (10%) cases all but one
rater was in agreement (IPF, n 2; NSIP, n 2; hypersensitivity
pneumonitis, n  2). In four cases all but two raters were in
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TABLE 4. INTRAOBSERVER AGREEMENT FOR CLINICIANS AND RADIOLOGISTS AT EACH STEP
Clinicians Radiologists
A B C A B
Steps [ (95% CI)] [ (95% CI)] [ (95% CI)] [ (95% CI)] [ (95% CI)]
1 and 2 0.75 (0.61, 0.90) 0.73 (0.59, 0.88) 0.80 (0.68, 0.92) 0.92 (0.84, 1.00) 0.90 (0.80, 0.99)
2 and 3 0.86 (0.75, 0.98) 0.75 (0.61, 0.89) 0.92 (0.84, 1.00) 0.95 (0.88, 1.00) 0.98 (0.92, 1.00)
3 and 4 0.60 (0.45, 0.76) 0.55 (0.39, 0.71) 0.50 (0.35, 0.66) 0.20 (0.06, 0.34) 0.32 (0.16, 0.48)
4 and 5 0.92 (0.83, 1.00) 0.89 (0.79, 0.99) 0.79 (0.66, 0.92) 0.84 (0.72, 0.96) 0.94 (0.88, 1.00)
agreement (RBILD, n  1; bronchiolar, n  3). In one case the
raters were equally divided between RBILD versus a bronchio-
lar disorder.
DISCUSSION
Assigning a diagnosis to a patient with interstitial lung disease
is difficult and at times imprecise. In clinical practice, pulmonary
physicians, radiologists, and pathologists are separated by time,
geographic location, and different schedules. This challenges the
pulmonary physician confronted with the actual patient in the
clinic to individually integrate and analyze the gathered clinical,
radiographic, and pathologic data and make decisions about a
given patient rather than discussing the data with the radiologist
and/or pathologist in a collective manner. In an attempt to im-
prove diagnostic accuracy the ATS/ERS consensus statement
recommended a dynamic integrated approach to the diagnosis
of interstitial lung diseases that involves an interaction between
clinicians, radiologists, and pathologists to achieve a final clinical,
radiologic, and pathologic diagnosis (14). In this study we exam-
ined whether such a dynamic interactive process impacted the
perceived diagnosis, and confidence level for that diagnosis, for
a group of consecutive patients with suspected idiopathic intersti-
tial pneumonia. We demonstrate that:
1. The level of agreement between observers and diagnostic
confidence improves as more data (clinical, radiographic,
and pathologic) are provided.
2. Patients may not require surgical lung biopsy when the
clinical and radiographic (HRCT) impression is consistent
with a confident diagnosis of IPF.
3. For non-IPF idiopathic interstitial pneumonias, a surgical
lung biopsy may be required as a final consensus diagnosis
is most influenced by the histopathologic pattern in this
setting.
This study quantifies how a dynamic exchange of clinical, radio-
graphic, and pathologic information changes the diagnostic impres-
sion of expert physicians when assigning a diagnosis of idiopathic
TABLE 5. AGREEMENT OF CLINICIANS AND RADIOLOGISTS WITH PATHOLOGIST IMPRESSION
Clinicians Radiologists
A B C A B
Step [ (95% CI)] [ (95% CI)] [ (95% CI)] [ (95% CI)] [ (95% CI)]
1 0.22 (0.07, 0.36) 0.22 (0.09, 0.36) 0.38 (0.23, 0.54) 0.09 (0.0, 0.21) 0.14 (0.02, 0.27)
2 0.34 (0.20, 0.48) 0.20 (0.05, 0.34) 0.39 (0.24, 0.55) 0.12 (0.0, 0.26) 0.17 (0.04, 0.30)
3 0.34 (0.20, 0.48) 0.32 (0.17, 0.47) 0.39 (0.23, 0.54) 0.13 (0.0, 0.26) 0.19 (0.05, 0.32)
4 0.76 (0.63, 0.88) 0.79 (0.67, 0.91) 0.74 (0.61, 0.88) 0.81 (0.69, 0.94) 0.92 (0.84, 1.00)
5 0.89 (0.80, 0.99) 0.78 (0.65, 0.91) 0.89 (0.79, 0.99) 0.87 (0.76, 0.97) 0.92 (0.84, 1.00)
The consensus diagnosis of the pathologists without clinical or radiographic information (Table 2) was used for Steps 1–3. The
consensus diagnosis of the pathologists after hearing the clinical/radiographic information and after a final group discussion
(Table 1) was used for Steps 4 and 5, respectively.
interstitial pneumonia. Exchanges of information lead to both
changes in diagnosis and improved confidence with the assigned
diagnosis. The effect of interaction between physicians seems
most critical for non-IPF idiopathic interstitial pneumonia cases.
After review of the clinical, radiographic, and pathologic infor-
mation the pathologists thought that IPF was the diagnosis in
30 cases. Of these 30 cases, the two radiologists and three clini-
cians each identified 14, 15, 22, 23, and 23 (respectively) after
the review of clinical/radiographic information before obtaining
histopathologic information. Importantly, in almost half of the
overall cases the histopathologic findings were critical in de-
termining the final diagnosis from each participant. The discus-
sion and exchange of clinical, radiographic, and histopathologic
information also tended to improve each participant’s confidence
in their diagnosis. This is important as diagnoses at any stage
rendered with a high level of confidence tended to correspond
with the final consensus diagnosis. This suggests that when a
physician expresses uncertainty about an idiopathic interstitial
pneumonia diagnosis, extra effort should be made to seek addi-
tional information and/or opinions with the hope of achieving
greater confidence in their diagnostic impression. Furthermore,
these data strongly support the role of surgical lung biopsy in
patients with a non-IPF HRCT and clinical scenario (1, 14).
A unique feature of this study is the lack of the arbitrary
assignment of a gold standard for the final diagnosis. By allowing
all participants the opportunity to change their initial diagnostic
interpretations we monitored how diagnoses changed with more
information and the level of agreement at each stage in the
evaluation process. Our data demonstrate that a change in the
final clinical–radiographic–pathologic diagnosis is particularly
likely to occur in patients with a clinical and radiographic sce-
nario suggestive of non-IPF idiopathic interstitial pneumonia.
Importantly, providing the clinical and radiographic information
to pathologists led to an alternative or clarified pathologic opin-
ion in 19% of the cases. These findings extend previous work
that evaluated agreement between clinicians, radiologists, and
pathologists (5, 10, 16, 21–24).
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TABLE 6. CASES IN WHICH INITIAL AND FINAL
PATHOLOGIC INTERPRETATION CHANGED
Initial Diagnosis Final Diagnosis
Hypersensitivity pneumonitis NSIP*
Organizing pneumonia NSIP
UIP ILD associated with CVID
Bronchiolar disease Pulmonary veno-occlusive disease
End-stage lung IPF
End-stage lung IPF
End-stage lung IPF
UIP NSIP*
UIP NSIP
Bronchiolar disease RBILD
Bronchiolar disease RBILD
Definition of abbreviations: CVID  common variable immunodeficiency; ILD 
interstitial lung disease; IPF  idiopathic pulmonary fibrosis; NSIP  nonspecific
interstitial pneumonia; RBILD  respiratory bronchiolitis interstitial lung disease;
UIP  usual interstitial pneumonia.
* These cases were associated with rheumatoid arthritis.
The level of agreement between participants was good at
onset and improved with discussion of additional clinical and
histopathologic information. The highest initial agreement was
between radiologists. Radiologists were also less likely than clini-
cians to believe that the clinical scenario was characteristic of
IPF and were more likely, compared with clinicians, to change
their diagnosis on the basis of histopathologic findings. Previous
work demonstrated the limited sensitivity (16, 24, 25) yet high
positive predictive value (10, 12, 16, 26) of HRCT for detecting
IPF. Our data highlight the value of clinicians reviewing the
actual HRCT with a radiologist versus relying on reported find-
ings. The greatest improvement for the clinician’s interobserver
TABLE 7. RELATIONSHIP BETWEEN CLINICIAN AND RADIOLOGIST LEVEL OF CONFIDENCE FOR DIAGNOSIS AND AGREEMENT
WITH FINAL PATHOLOGIST CONSENSUS DIAGNOSIS
Self-reported Confidence Level†
Clinician A Clinician B Clinician C Radiologist A Radiologist B
Diagnosis Matched Final
Pathologist Consensus High Low High Low High Low High Low High Low
Step 1
Yes 15 18 21 10 12 25 7 14 9 16
No 3 22 8 19 0 20 5 32 8 25
p Value* 0.009 0.008 0.005 0.097 0.39
Step 2
Yes 17 22 20 9 12 27 6 17 10 16
No 4 15 12 17 2 16 4 31 9 23
p –Value* 0.14 0.064 0.18 0.17 0.57
Step 3
Yes 16 22 24 12 12 28 7 16 13 14
No 3 17 12 10 2 15 4 31 10 21
p –Value* 0.044 0.41 0.19 0.093 0.28
Step 4
Yes 38 13 35 17 36 13 31 18 32 22
No 0 7 5 1 0 8 2 7 2 1
p Value*  0.001 0.665  0.001 0.031 1
Step 5
Yes 43 11 43 6 38 14 38 15 37 17
No 0 4 5 3 0 3 2 3 2 1
p Value* 0.003 0.10 0.026 0.17 1
* Fisher’s exact test.
† Raters were asked to grade their level of confidence in diagnosis as 1  high, 2  probable, 3  possible, and 4  definitely not. A confidence level of 1 was
considered high, and levels of 2–4 were considered low. Comparisons in which the 2  2 subtable entries do not sum to 58 patients indicate one or more missing
confidence level values.
agreement occurred after the discussion of clinical and radio-
graphic features with radiologists.
The ATS/ERS consensus panel on idiopathic pulmonary fi-
brosis states that in the absence of a surgical lung biopsy, the
diagnosis of IPF/UIP remains uncertain. However, the panel
proposed diagnostic criteria that could be used by clinicians to
increase the likelihood of a correct clinical diagnosis of IPF
(Table 8). In the immunocompetent adult, the presence of all
of the major diagnostic criteria along with at least three of the
four minor criteria was recommended. These criteria were not
prospectively tested. However, the clinicians involved in the
present study were coauthors of the Statement and followed
these principles in defining cases of idiopathic interstitial pneu-
monia. This may account for some of the differences seen be-
tween the clinicians and radiologists involved in this study.
A limitation of our study is the use of participants with sig-
nificant expertise in the field of interstitial lung disease. Some
investigators have suggested that expert radiologists exhibit im-
proved interobserver agreement compared with radiologists with
lesser expertise (27–30). No similar data have examined this
topic in the evaluation of suspected idiopathic interstitial pneu-
monia by less experienced clinicians. Additional data are re-
quired to assess the role of a dynamic, interactive diagnostic
process in the hands of less experienced clinicians, radiologists,
and pathologists. These data also do not address how individual
personalities may have impacted the degree of agreement (or
disagreement) at various steps throughout the experiment. The
participants in this study are recognized, senior experts and are
accustomed to rendering an “expert opinion.” As such, other
physicians may render diagnostic opinions that are more (or
less) malleable compared with this study group.
In summary, our data quantify the essence of a dynamic clinical,
radiographic, and pathologic approach to the diagnosis of patients
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TABLE 8. CONFIDENT DIAGNOSIS OF USUAL INTERSTITIAL
PNEUMONIA IN AN IMMUNOCOMPETENT ADULT IN THE
ABSENCE OF SURGICAL BIOPSY
Major criteria (all must be present)
1. Exclusion of other known causes of ILD, such as certain drug toxicities,
environmental exposures, and connective tissue diseases
2. Abnormal pulmonary function studies that include evidence of restriction
(reduced VC, often with an increased FEV1/FVC ratio) and impaired gas
exchange [increased (A–a)PO2 with rest or exercise or decreased DLCO]
3. Bibasilar reticular abnormalities with minimal ground glass opacities on HRCT
scans
4. Transbronchial lung biopsy or bronchoalveolar lavage showing no features to
support an alternative diagnosis
Minor criteria (three of four must be present)
1. Age, 50 yr
2. Insidious onset of otherwise unexplained dyspnea on exertion
3. Duration of illness greater than 3 mo
4. Bibasilar, inspiratory crackles (dry or “Velcro” type in quality)
Definition of abbreviations: (A–a)PO2  alveolar–arterial pressure difference for
oxygen; DLCO  diffusing capacity of the lung for carbon monoxide; HRCT 
high-resolution computed tomography; ILD  interstitial lung disease; VC  vital
capacity.
From Reference 31.
with suspected idiopathic interstitial pneumonia. We believe that
at a minimum the evaluation of patients with idiopathic interstitial
pneumonia should include an interaction between the clinician
and thoracic radiologist. If this initial step results in a confident
diagnosis of IPF a surgical lung biopsy is not required. In all
other cases a surgical lung biopsy is likely to impact the final
diagnosis and should be performed if possible. If a surgical lung
biopsy is available, the pathologist should be involved in the
diagnostic analytic discussion. It appears the current gold stan-
dard for the diagnosis of idiopathic interstitial pneumonia is
a dynamic integrated process that requires direct interaction
between clinicians and radiologists as well as pathologists when
a surgical lung biopsy is available. Further research to clarify
this process, examine its effect in the hands of less experienced
physicians, and evaluate the implications in terms of response
to therapy and prognosis is required.
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